Access to CD4 testing for rural HIV patients: Findings from a cohort study in Zimbabwe

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Vogt, Florian ^a   Tayler Smith, Katie ^a   Bernasconi, Andrea ^a,b   Makondo, Eliphas ^c   Taziwa, Fabian ^a   Moyo, Buhlebenkosi ^a   Havazvidi, Liberty ^a   Satyanarayana, Srinath ^d   Manzi, Marcel ^a   Khogali, Mohammed ^a   Reid, Anthony ^a  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b Operational Research Unit Luxembourg Médecins Sans Frontières/Doctors Without Borders ^*  (France)

^c MINISTRY OF HEALTH AND CHILD CARE   (Zimbabwe)

^d INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMPARATIVE STUDY; CONSULTATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; RURAL POPULATION; TIME TO TREATMENT; TREATMENT DURATION; URBAN POPULATION; ZIMBABWE; ADOLESCENT; HEALTH CARE DELIVERY; HIV INFECTIONS; IMMUNOLOGY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MALE; RETROSPECTIVE STUDIES; RURAL POPULATION; YOUNG ADULT; ZIMBABWE;

EID: 84939214571     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0129166     Document Type: Article

References (41)

1. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach June 2013. Geneva: World Health Organization; 2013. Available: http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727-eng.pdf. Accessed 14 October 2014.
2. Zimbabwe National Statistics Agency, ICF International. Zimbabwe Demographic and Health Survey 2010-11. Calverton, Maryland: Zimbabwe National Statistics Agency, ICF International; 2012 Available: http://www.zimstat.co.zw/dmdocuments/Census/ZDHS2011/ZDHS2011KEY.pdf. Accessed 14 October 2014.
3. Ministry of Health and Child Welfare of Zimbabwe. Guidelines for Antiretroviral Therapy in Zimbabwe. Harare: Ministry of Health and Child Welfare of Zimbabwe; 2010. Available: http://apps.who.int/medicinedocs/documents/s19254en/s19254en.pdf. Accessed 14 October 2014.
4. Ministry of Health and Child Care of Zimbabwe. Guidelines for Antiretroviral Therapy for the Prevention and Treatment of HIV in Zimbabwe. Harare: Ministry of Health and Child Care of Zimbabwe; 2013. Available: http://www.nac.org.zw/sites/default/files/2013%20Zimbabwe%20ARV%20Guidelines%20% 20Main%20Document%20(1).pdf. Accessed 14 October 2014.
5. World Health Organization. Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults. Geneva: World Health Organization; 2006. Available: http://www. who.int/hiv/pub/guidelines/ctxguidelines.pdf?ua=1. Accessed 14 October 2014.
6. World Health Organization. Rapid advice: diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children. Geneva: World Health Organization; 2011. Available: http://whqlibdoc.who.int/publications/2011/9789241502979-eng.pdf?ua=1. Accessed 14 October 2014.
7. Justman JE, Koblavi-Deme S, Tanuri A, Goldberg A, Gonzalez LF, Gwynn CR. Developing laboratory systems and infrastructure for HIV scale-up: A tool for health systems strengthening in resource-limited settings. J Acquir Immune Defic Syndr. 2009; 52 Suppl 1:S30-33. doi:10.1097/QAI.0b013e3181bbc9f5 PMID:19858935
8. Cohen GM. Access to diagnostics in support of HIV/AIDS and tuberculosis treatment in developing countries. AIDS. 2007; 21 Suppl 4:S81-87. PMID:17620757
9. Alemnji G, Nkengasong JN, Parekh BS. HIV testing in developing countries: what is required? Indian J Med Res. 2011; 134:779-786. doi:10.4103/0971-5916.92625 PMID:22310813
10. Peter T, Badrichani A, Wu E, Freeman R, Ncube B, Ariki F, et al. Challenges in implementing CD4 testing in resource-limited settings. Cytometry B Clin Cytom. 2008; 74 Suppl 1:S123-130. doi:10.1002/cyto.b.20416 PMID:18348208
11. Marinucci F, Medina-Moreno S, Paterniti AD, Wattleworth M, Redfield RR. Decentralization of CD4 testing in resource-limited settings: 7 years of experience in six African countries. Cytometry A. 2011; 79:368-374. doi:10.1002/cyto.a.21064 PMID:21495181
12. Posse M, Meheus F, van Asten H, van der Ven A, Baltussen R. Barriers to access to antiretroviral treatment in developing countries: a review. Trop Med Int Health. 2008; 13:904-913. doi:10.1111/j.1365-3156.2008.02091.x PMID:18466183
13. Petti CA, Polage CR, Quinn TC, Ronald AR, Sande MA. Laboratory medicine in Africa: a barrier to effective health care. Clin Infect Dis. 2006; 42:377-382. PMID:16392084
14. Sieleunou I, Souleymanou M, Schonenberger AM, Menten J, Boelaert M. Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Trop Med Int Health. 2009; 14:36-43. doi:10.1111/j.1365-3156.2008.02146.x PMID:19508440
15. Sutcliffe CG, van Dijk JH, Bolton-Moore C, Cotham M, Tambatamba B, Moss WJ. Differences in presentation, treatment initiation, and response among children infected with human immunodeficiency virus in urban and rural Zambia. Pediatr Infect Dis J. 2010; 29:849-854. doi:10.1097/INF.0b013e3181e753a8 PMID:20526227
16. Fredlund VG, Nash J. How far should they walk? Increasing antiretroviral therapy access in a rural community in northern KwaZulu-Natal, South Africa. J Infect Dis. 2007; 196 Suppl 3:S469-473. doi:10. 1086/521115 PMID:18181696
17. Wilson LE, Korthuis T, Fleishman JA, Conviser R, Lawrence PB, Moore RD, Gebo KA, et al. HIV-related medical service use by rural/urban residents: a multistate perspective. AIDS Care. 2013; 23:971-979.
18. Posse M, Baltussen R. Barriers to access to antiretroviral treatment in Mozambique, as perceived by patients and health workers in urban and rural settings. AIDS Patient Care STDS. 2009; 23:867-875. doi:10.1089/apc.2009.0050 PMID:19803678
19. Ohl M, Lund B, Belperio PS, Goetz MB, Rimland D, Richardson K, et al. Rural residence and adoption of a novel HIV therapy in a national, equal-access healthcare system. AIDS Behav. 2013; 17:250-259. doi:10.1007/s10461-011-0107-8 PMID:22205324
20. Yao J, Agadjanian V, Murray AT. Spatial and social inequities in HIV testing utilization in the context of rapid scale-up of HIV/AIDS services in rural Mozambique. Health Place. 2014; 28C:133-141.
21. Dalal W, Feikin DR, Amolloh M, Ransom R, Burke H, Lugalia F, et al. Home-based HIV testing and counseling in rural and urban Kenyan communities. J Acquir Immune Defic Syndr. 2013; 62:e47-54. doi:10.1097/QAI.0b013e318276bea0 PMID:23075916
22. Weis KE, Liese AD, Hussey J, Gibson JJ, Duffus WA. Associations of rural residence with timing of HIV diagnosis and stage of disease at diagnosis, South Carolina 2001-2005. J Rural Health. 2010; 26:105-112. doi:10.1111/j.1748-0361.2010.00271.x PMID:20446996
23. Wools-Kaloustian K, Kimaiyo S. Extending HIV care in resource-limited settings. Curr HIV/AIDS. 2006; Rep 3:182-186. PMID:17032578
24. Zimbabwe National Statistics Agency. Zimbabwe National Population Census 2012. Harare: Zimbabwe National Statistics Agency; 2012. Available: http://www.zimstat.co.zw/dmdocuments/Census/CensusResults2012/National-Report.pdf. Accessed 14 October 2014.
25. FUCHIA Version 1.7.1 [computer programme]. Paris: Epicentre; 2013.
26. STATA Version 11.2 [computer programme]. College Station, Texas: StataCorp; 2011.
27. Desai D, Wu G, Zaman MH. Tackling HIV through robust diagnostics in the developing world: current status and future opportunities. Lab Chip. 2011; 11:194-211. doi:10.1039/c0lc00340a PMID:21125097
28. Setty MK, Hewlett IK. Point of Care Technologies for HIV. AIDS Res Treat. 2014; 2014:497046. doi:10. 1155/2014/497046 PMID:24579041
29. Wynberg E, Cooke G, Shroufi A, Reid SD, Ford N. Impact of point-of-care CD4 testing on linkage to HIV care: a systematic review. J Int AIDS Soc. 2014; 17:18809. doi:10.7448/IAS.17.1.18809 PMID:24447595
30. Jani IV, Sitoe NE, Alfai ER, Chongo PL, Quevedo JI, Rocha BM, et al. Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet. 2011; 378:1572-1579. doi:10.1016/S0140-6736(11)61052-0 PMID:21951656
31. Muchedzi A, Chadambuka A, Chikwinya B, Mahomva A. Evaluating the effect of the use of point-ofcare CD4 machines on access to antiretroviral therapy (ART) eligibility screening and ART initiation for HIV-positive pregnant women in Zimbabwe: towards elimination of new paediatric HIV infection by 2015. Washington DC: 19th International AIDS Conference; 2012: Abstract no. TUPDE0204. Available: http://iasociety.org/Abstracts/A200745824.aspx. Accessed 14 October 2014.
32. Schacht CD, Lucas C, Sitoe N, Manuel I, Tobaiwa O, Ramanlal N, et al. Point-of-care CD4 testing leads to increased uptake of antiretroviral therapy among pregnant women in Gaza province, Mozambique. Washington DC: 19th International AIDS Conference; 2012: Abstract no. THPE079. Available: http://iasociety.org/Abstracts/A200745586.aspx. Accessed 14 October 2014.
33. van Rooyen H, Barnabas RV, Baeten JM, Phakathi Z, Joseph P, Krows M, et al. High HIV testing uptake and linkage to care in a novel program of home-based HIV counseling and testing with facilitated referral in KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr. 2013; 64:e1-8. doi:10.1097/QAI.0b013e31829b567d PMID:23714740
34. Galiwango RM, Lubyayi L, Musoke R, Kalibbala S, Buwembo M, Kasule J, et al. Field evaluation of PIMA point-of-care CD4 testing in Rakai, Uganda. PLoS One. 2014; 9:e88928. doi:10.1371/journal. pone.0088928 PMID:24614083
35. Fajardo E, Metcalf C, Maman D, Chaillet P, Piriou E, et al. High frequency of invalid CD4 test resulrs using the Alere Pima CD4 point-of-care (POC) analyzer in MSF field projects in nine countries. London: Médecins Sans Frontières (MSF) Scientific Day; 2014. Available: http://cdn.f1000.com/posters/docs/261652718. Accessed 14 October 2014.
36. Shott JP, Iga B, Makumbi F, Luswata C, Kagulire C, Nammanda J, et al. CD4 stabilization tubes provide improved accuracy of absolute CD4 T-cell counts compared to standard k3 EDTA tubes in human immunodeficiency virus immunologic monitoring in resource-poor settings. Clin Vaccine Immunol. 2008; 15:1623-1624. doi:10.1128/CVI.00176-08 PMID:18753336
37. Bui N, Nayak P, McIntyre C. Use of CD4 Stabilization Tubes for QC Specimens in Resource-Limited Settings. San Jose, California: Becton Dickinson Biosciences; 2009.
38. Stevens WS, Scott LE, Crowe SM. Quantifying HIV for monitoring antiretroviral therapy in resourcepoor settings. J Infect Dis. 2010; 201 Suppl 1:S16-26. doi:10.1086/650392 PMID:20225942
39. Smit PW, Sollis KA, Fiscus S, Ford N, Vitoria M, Essajee S, et al. Systematic review of the use of dried blood spots for monitoring HIV viral load and for early infant diagnosis. PLoS One. 2014; 9:e86461. doi:10.1371/journal.pone.0086461 PMID:24603442
40. Mwaba P, Cassol S, Nunn A, Pilon R, Chintu C, Janes M, et al. Whole blood versus plasma spots for measurement of HIV-1 viral load in HIV-infected African patients. Lancet. 2003; 362:2067-2068. PMID:14697808
41. Johannessen A, Garrido C, Zahonero N, Sandvik L, Naman E, Kivuyo SL, et al. Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania. Clin Infect Dis. 2009; 49:976-981. doi:10.1086/605502 PMID:19663598